title: The use of gadolinium-based contrast agents should be discontinued until proven safe.
authors.affiliation: Djehuty Biomed Consulting, 106 Rugged Drive, Red Oak, TX, 75154, USA.
authors.forename: Stacy Matthews
authors.initials: SM
authors.lastname: Branch
authors.affiliation: Department of Radiology, The Ohio State University Medical School, Columbus, OH, 43210, USA.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Tweedle
authors.forename: Colin G
authors.initials: CG
authors.lastname: Orton
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000633:toxicity; D004335:Drug and Narcotic Control; D004781:Environmental Exposure / Q000517:prevention & control; D005682:Gadolinium / Q000633:toxicity; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D011859:Radiography; D012306:Risk
chemical_list: D003287:Contrast Media; D005682:Gadolinium